Browse through 1,551 product recalls and safety alerts. Filter by hazard level, status, or search for specific products.
Abiomed recalled 9,177 Automated Impella Controllers on September 16, 2025. The recall follows reports of purge pressure issues due to purge retainer failures. Patients and healthcare providers must stop using the devices immediately.
FUJIFILM Healthcare Americas recalled 16 units of the CH-200 X-ray tube support on September 15, 2025, due to a potential shaft failure. The broken shaft could render protective components ineffective, posing a high risk during operation. Healthcare providers and patients must stop using the device immediately.
Alcon Research LLC recalled 28,323 CONSTELLATION ULTRAVIT and HYPERVIT devices on September 15, 2025, due to a high hazard risk. The recall affects products distributed worldwide, including multiple states in the U.S. and several countries.
Graviti Pharmaceuticals recalled 46,512 bottles of Bupropion Hydrochloride Extended-Release Tablets on September 15, 2025. The recall stems from failed tablet specifications that could affect safety and efficacy. The product was distributed to pharmacies nationwide.
American Health Packaging recalled 360 cartons of Carbamazepine Extended-Release Tablets on September 15, 2025. The tablets fail to meet dissolution specifications, posing a risk to patients. Consumers should stop using the product immediately and consult healthcare providers for guidance.
Private Label Skin Care recalled its edunn clarity BP Treatment Cleanser on September 12, 2025. Elevated benzene levels prompted the recall after post-consumer awareness. The product was distributed in California and Georgia.
Private Label Skin Care recalled 125 units of ARTISAN OF SKIN Benzoyl Peroxide 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers should stop using the product immediately and seek guidance.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its 7 oz Acne Treatment on September 12, 2025. Elevated levels of benzene prompted the recall, classified as Class II. The affected product was distributed in California and Georgia only.
Private Label Skin Care recalled Benzaderm BPO Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall affecting consumers in California and Georgia. No injuries have been reported.
GE HealthCare recalled 82 units of the Millenium Myosight gamma camera on September 12, 2025. The recall affects systems that may lack sufficient support during transport, posing a risk of detector falls. This defect can result in life-threatening injuries.
Major Pharmaceuticals recalled 2,064 blister packs of Chlorpromazine Hydrochloride Tablets on September 12, 2025. The recall follows the discovery of N-Nitroso Desmethyl Chlorpromazine exceeding safe limits. Consumers must stop using this product immediately and consult healthcare providers for guidance.
GE HealthCare recalled 205 dual-head nuclear medicine gamma cameras on September 12, 2025. The recall affects models that may have been relocated without proper detector support, leading to potential falls. This issue poses a high risk of life-threatening injury.
Major Pharmaceuticals recalled 866 blister packs of Chlorpromazine Hydrochloride Tablets on September 12, 2025. The recall follows the detection of N-Nitroso Desmethyl Chlorpromazine above safe limits. The affected products were distributed nationwide and are classified as a Class II hazard.
Unique Pharmaceuticals Labs recalled 9,936 bottles of Cetirizine Hydrochloride Tablets on September 12, 2025. The tablets were imprinted with the wrong ID, posing a potential health risk. Consumers should stop using the product immediately and seek guidance from healthcare providers.
GE HealthCare recalled 37 nuclear medicine gamma cameras on September 12, 2025. The recall follows concerns that inadequate detector support during transport could lead to life-threatening falls. The affected systems are past the End of Guaranteed Service and pose serious risks to patients and healthcare providers.
GE HealthCare recalled 292 nuclear medicine gamma cameras on September 12, 2025. The devices may have been relocated without proper support, risking detector falls. This poses a serious risk of life-threatening injuries.
UIH Technologies recalled two units of the uEXPLORER MD system on September 12, 2025. Third-party covers can trap between the patient table and gantry, causing mechanical interference. Healthcare providers must stop using the device immediately and follow recall instructions.
UIH Technologies recalled 95 units of its uMI 550 Positron Emission Tomography and Computed Tomography System on September 12, 2025. Third-party outer covers can trap between the patient table and gantry, posing a mechanical interference risk. Patients and healthcare providers must stop using the device immediately.